Krystal Biotech Cash Flow Statement
NASDAQ: KRYSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Krystal Biotech free cash flow
In fiscal 2025, Krystal Biotech generated $200.9 million of operating cash flow and spent $12.0 million on capital expenditures. That left free cash flow of $188.9 million, a free-cash-flow margin of 48.5% of revenue. Free cash flow was up 58.5% from the prior year's $119.2 million.
Summary generated from market data by MetaCap's automated system. Methodology
Krystal Biotech cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20212022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 204.83M | 89.16M | 10.93M | -139.97M | -69.57M | -32.17M | -19.09M | -10.89M | -7.92M | -1.15M |
| Net Income growth (YoY) | +129.74% | +715.58% | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 5.72M | 5.97M | 5.01M | 4.05M | 2.77M | 1.85M | 1.09M | 141.00K | 23.00K | 2.00K |
| Stock-Based Compensation | 54.51M | 49.13M | 39.93M | 33.23M | 15.32M | 3.27M | 1.24M | 792.00K | 246.00K | 33.00K |
| Change in Working Capital | -29.85M | -80.89M | -48.23M | -1.87M | 21.00K | -1.14M | -1.07M | -209.00K | 56.00K | -204.00K |
| Operating Cash Flow | 200.87M | 123.42M | -88.80M | -100.57M | -47.94M | -26.08M | -18.69M | -9.45M | -3.89M | -1.31M |
| Capital Expenditures | -11.95M | -4.24M | -11.80M | -52.98M | -68.34M | -14.84M | -6.40M | -2.23M | -210.00K | -15.00K |
| Investing Cash Flow | -58.42M | -163.44M | 82.64M | -114.08M | -226.77M | -11.18M | -4.99M | -10.32M | -210.00K | -15.00K |
| Financing Cash Flow | 8.71M | 27.01M | 202.75M | 35.35M | 347.69M | 118.02M | 107.53M | 73.85M | 51.77M | 3.25M |
| Net Change in Cash | 151.44M | -13.46M | 196.43M | -179.35M | 72.98M | 80.75M | 83.84M | 54.08M | 47.67M | 1.92M |
| Free Cash Flow | 188.91M | 119.18M | -100.60M | -153.55M | -116.27M | -40.93M | -25.09M | -11.68M | -4.10M | -1.33M |
This table shows 10 annual periods of Krystal Biotech's cash flow statement, from FY 2025 back to FY 2016, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow KRYS's reporting calendar. What is a cash flow statement?